• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Vertera Spine wins 510(k) for Coalesce interbody fusion device

Vertera Spine wins 510(k) for Coalesce interbody fusion device

July 25, 2017 By Fink Densford

Vertera Spine

Vertera Spine said today it won FDA 510(k) clearance for its Coalesce lumbar interbody fusion device for use in anterior, transforaminal, posterior and lateral lumbar interbody fusion procedures.

The Atlanta-based company said its newly cleared Coalesce fusion device features the company’s proprietary porous PEEK biomaterial. Vertera spine said it will be launching the Coalesce for TLIF and PLIF procedures in multiple configurations later this year.

“Based on the initial success with the Cohere Cervical porous PEEK device, we saw the need to apply this innovative technology to other spine applications. We are pleased to have received FDA clearance for Coalesce and look forward to further serving surgeons’ clinical demands for a durable fusion device that successfully osseointegrates and allows for integration to be assessed on imaging,” CEO Chris Lee said in a press release.

“I initially became convinced of porous PEEK’s clinical benefits by the successful ACDF outcomes I obtained with the Cohere device. However, I believe porous PEEK’s true value will be demonstrated with the Coalesce device in lumbar procedures where the biologic fusion environment can be more challenging, and the biomechanics more demanding on fusion devices,” Dr. Gurvinder Deol of Raleigh, N.C.’s WakeMed Health and Hospitals said in a prepared statement.

“Our latest results show that porous PEEK is able to effectively osseointegrate by forming a mechanical and biological interface with bone. Our next steps are to translate what we have learned in animal models to the clinical setting by assessing this bony ingrowth into porous PEEK on X-Ray and CT,” Dr. Ken Gall of Duke University said in prepared remarks.

Last month, Vertera Spine raised $3.1 million, according to regulatory documents. The company offered equity in exchange for a minimum investment of $2,000 and 29 investors contributed to the round, beginning Feb 7.

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance, Spine Tagged With: Vertera Spine

More recent news

  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Philips prices $1.1B offering to pay off debt, finance green projects
  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy